Literature DB >> 7491546

Inflammatory predictors for the development of the adult respiratory distress syndrome.

P T Reid, S C Donnelly, C Haslett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7491546      PMCID: PMC475011          DOI: 10.1136/thx.50.10.1023

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  37 in total

Review 1.  The use of radionuclide techniques in the assessment of alveolar-capillary membrane permeability on the intensive care unit.

Authors:  D N Hunter; C J Morgan; T W Evans
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 2.  Pulmonary pathology of the adult respiratory distress syndrome.

Authors:  J F Tomashefski
Journal:  Clin Chest Med       Date:  1990-12       Impact factor: 2.878

Review 3.  NHLBI workshop summary. Workshop on techniques to evaluate lung alveolar-microvascular injury.

Authors:  N C Staub; R W Hyde; E Crandall
Journal:  Am Rev Respir Dis       Date:  1990-04

4.  Plasma thrombomodulin in health and diseases.

Authors:  S Takano; S Kimura; S Ohdama; N Aoki
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

5.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

6.  Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome.

Authors:  R C Bone; C J Fisher; T P Clemmer; G J Slotman; C A Metz
Journal:  Chest       Date:  1987-12       Impact factor: 9.410

7.  Immunoreactive interleukin-1 in bronchoalveolar lavage fluid of high-risk patients and patients with the adult respiratory distress syndrome.

Authors:  T M Siler; J E Swierkosz; T M Hyers; A A Fowler; R O Webster
Journal:  Exp Lung Res       Date:  1989-12       Impact factor: 2.459

8.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung.

Authors:  S L Kunkel; T Standiford; K Kasahara; R M Strieter
Journal:  Exp Lung Res       Date:  1991 Jan-Feb       Impact factor: 2.459

9.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.

Authors:  D B Rubin; J P Wiener-Kronish; J F Murray; D R Green; J Turner; J M Luce; A B Montgomery; J D Marks; M A Matthay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

10.  Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group.

Authors:  R C Bone; G Slotman; R Maunder; H Silverman; T M Hyers; M D Kerstein; J J Ursprung
Journal:  Chest       Date:  1989-07       Impact factor: 9.410

View more
  6 in total

Review 1.  Ventilator induced lung injury and infection in the critically ill.

Authors:  S V Baudouin
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 2.  Bedside measurement of pulmonary capillary permeability in patients with acute lung injury. What have we learned?

Authors:  G M Rocker
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 3.  Identifying patients with ARDS: time for a different approach.

Authors:  D P Schuster
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

4.  Macrophage Migration Inhibitor Promoted the Intrahepatic Bile Duct Injury in Rats with Severe Acute Pancreatitis.

Authors:  Bin Wang; Kai-Liang Zhao; Wen-Juan Hu; Teng Zuo; You-Ming Ding; Wei-Xing Wang
Journal:  Dig Dis Sci       Date:  2018-11-22       Impact factor: 3.199

5.  Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model.

Authors:  L Tremblay; F Valenza; S P Ribeiro; J Li; A S Slutsky
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 6.  The role of interleukin-8 and its receptors in inflammatory lung disease: implications for therapy.

Authors:  James E Pease; Ian Sabroe
Journal:  Am J Respir Med       Date:  2002
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.